Swathi Veeroju
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
Journal: Communications biology
Published: January 21, 2022
Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
Journal: International journal of molecular sciences
Published: December 22, 2020
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
Journal: Communications biology
Published: August 26, 2020
Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension.
Journal: The European respiratory journal
Published: February 19, 2020
Effect of p53 activation on experimental right ventricular hypertrophy.
Journal: PloS one
Published: January 20, 2020
Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: December 18, 2018
Response to: Comment on "Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding".
Journal: BioMed research international
Published: October 30, 2018
ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: September 15, 2017
Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding.
Journal: BioMed research international
Published: July 07, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026